Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nautilus Biotechnology, Inc. | 45,000 | reported | 14 Jun 2024 | tx 3+176,467 |
| BioAge Labs, Inc. | 22,000 | reported | 10 Jun 2026 | tx 14+3,277,170−9,433,835 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Jun 2026 | GRANT_AWARD | BioAge Labs, Inc. | 22,000 | 0.00 USD | deriv |
| 07 Aug 2025 | GRANT_AWARD | BioAge Labs, Inc. | 22,000 | 0.00 USD | deriv |
| 01 Oct 2024 | PURCHASE | BioAge Labs, Inc. | 126,793 | 19.73 USD | |
| 02 Oct 2024 | PURCHASE | BioAge Labs, Inc. | 67,096 | 19.73 USD | |
| 03 Oct 2024 | PURCHASE | BioAge Labs, Inc. | 25,306 | 19.90 USD | |
| 27 Sept 2024 | CONVERSION | BioAge Labs, Inc. | 189,609 | — | |
| 27 Sept 2024 | PURCHASE | BioAge Labs, Inc. | 900,000 | 18.00 USD | |
| 27 Sept 2024 | CONVERSION | BioAge Labs, Inc. | 413,100 | — | |
| 27 Sept 2024 | CONVERSION | BioAge Labs, Inc. | 855,972 | — | |
| 27 Sept 2024 | CONVERSION | BioAge Labs, Inc. | 655,294 | — | |
| 27 Sept 2024 | CONVERSION | BioAge Labs, Inc. | 846,152 | — | deriv |
| 27 Sept 2024 | CONVERSION | BioAge Labs, Inc. | 2,924,318 | — | deriv |
| 27 Sept 2024 | CONVERSION | BioAge Labs, Inc. | 1,843,502 | — | deriv |
| 27 Sept 2024 | CONVERSION | BioAge Labs, Inc. | 3,819,863 | — | deriv |
| 14 Jun 2024 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 45,000 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 45,000 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 86,467 | 0.00 USD | deriv |